Oncternal Therapeutics (ONCT)
(Delayed Data from NSDQ)
$7.36 USD
+0.36 (5.14%)
Updated Jul 22, 2024 04:00 PM ET
3-Hold of 5 3
F Value C Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -3.03 |
EPS Last Quarter | -2.83 |
Last EPS Surprise | 1.74% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -11.63 |
Next Year | -10.28 |
EPS (TTM) | -12.34 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.24M | 0.24M | 1.28M | 0.70M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 0.28M | 0.28M | 1.39M | 0.80M |
Low Estimate | 0.20M | 0.20M | 1.17M | 0.60M |
Year ago Sales | 0.11M | 0.18M | 0.79M | 1.28M |
Year over Year Growth Est. | 118.18% | 33.33% | 63.06% | -45.31% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -3.03 | -3.04 | -11.63 | -10.28 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -3.15 | -2.74 | -10.96 | -8.59 |
High Estimate | -2.89 | -2.74 | -10.96 | -8.59 |
Low Estimate | -3.15 | -3.22 | -12.59 | -12.00 |
Year ago EPS | -3.00 | -3.40 | -13.43 | -11.63 |
Year over Year Growth Est. | -1.00% | 10.59% | 13.40% | 11.61% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -3.03 | -3.04 | -11.63 | -10.28 |
7 Days Ago | -3.03 | -3.04 | -11.63 | -10.28 |
30 Days Ago | -3.03 | -3.04 | -11.63 | -10.28 |
60 Days Ago | -2.58 | -2.57 | -10.12 | -9.37 |
90 Days Ago | -2.61 | -2.62 | -10.67 | -9.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -3.03 | -3.04 | -11.63 | -10.28 |
Zacks Consensus Estimate | -3.03 | -3.04 | -11.63 | -10.28 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.83 | -3.11 | -3.40 | -3.00 | NA |
Estimate | -2.88 | -3.09 | -3.00 | -3.40 | NA |
Difference | 0.05 | -0.02 | -0.40 | 0.40 | 0.01 |
Surprise | 1.74% | -0.65% | -13.33% | 11.76% | -0.12% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more